Unilateral Glaucoma 

  • Author: Ingrid U Scott, MD, MPH; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Mar 29, 2012
 

Background

While any type of glaucoma can be unilateral, primary open-angle glaucoma, primary angle-closure glaucoma, primary infantile glaucoma, juvenile-onset glaucoma, and pigmentary glaucoma are generally bilateral diseases, the severity of which may be asymmetric in the two eyes.

This article reviews glaucoma associated with increased episcleral venous pressure (EVP) and glaucoma associated with iridocorneal endothelial (ICE) syndrome.

Several etiologies of unilateral glaucoma are discussed in detail in other articles, including Glaucoma, Pseudoexfoliation; Glaucoma, Uveitic; Glaucoma, Lens-Particle; Glaucoma, Drug-Induced; Glaucoma, Neovascular; Glaucoma, Intraocular Tumors; Glaucoma, Hyphema; Glaucoma, Angle Recession; and Glaucoma, Malignant.

Next

Pathophysiology

Increased EVP

In the early 1900s, Lauber provided histological evidence that the canal of Schlemm was connected to the episcleral venous network. Aqueous humor drains via the anterior surface of the ciliary body or through the trabecular meshwork, Schlemm canal, collector channels, and, subsequently, aqueous veins. These pathways have been termed unconventional and conventional, respectively.

While the unconventional pathway is independent of pressure, outflow via the conventional route is passive and depends largely on the difference between the intraocular pressure (IOP) and EVP; as EVP increases relative to IOP, or as resistance increases, flow decreases.

The 3 general pathophysiological mechanisms of increased EVP are arteriovenous anomalies, venous obstruction, and idiopathic. Arteriovenous anomalies associated with increased EVP include carotid-cavernous sinus fistula, orbital varix, Sturge-Weber syndrome, orbital-meningeal shunts, carotid-jugular venous shunts, and intraocular vascular shunts. Venous obstruction may be caused by a retrobulbar tumor, thyroid ophthalmopathy, superior vena cava syndrome, congestive heart failure, thrombosis of the cavernous sinus or orbital vein, vasculitis involving the episcleral or orbital vein, and jugular vein obstruction.

ICE syndrome

The pathophysiological mechanism underlying ICE syndrome remains unknown. However, the finding of chronic inflammatory cells in the corneal specimens of patients with ICE syndrome suggests a viral etiology. In a study using polymerase chain reaction techniques, 16 of 25 corneas from patients with ICE syndrome and 4 of 6 patients with herpetic keratitis were positive for herpes simplex virus.

Glaucoma associated with ICE syndrome is believed to be due to trabecular meshwork obstruction caused by peripheral anterior synechiae or, less commonly, an abnormal cellular membrane.

Previous
Next

Epidemiology

Frequency

United States

The frequency of glaucoma associated with increased EVP or with ICE syndrome is unknown.

Glaucoma has been reported to occur in 30% of patients with Sturge-Weber syndrome, 5% of patients with thyroid ophthalmopathy, 11.6% of patients with scleritis, and 4% of patients with episcleritis.

Mortality/Morbidity

  • Glaucoma is the third leading cause of blindness in the United States.
  • Because glaucoma may progress insidiously without causing symptoms, progressive glaucomatous damage may occur without the patient even being aware of the diagnosis.
  • Prompt and continued control of IOP can prevent ocular damage due to glaucoma.

Sex

Age

  • Spontaneous carotid-cavernous sinus fistulae typically occur in middle-aged to elderly individuals, while traumatic carotid-cavernous sinus fistulae occur most commonly in young persons.
  • It has been reported that 60% of patients with glaucoma associated with Sturge-Weber syndrome acquire glaucoma before age 2 years, and the remaining patients develop glaucoma later in childhood or in early adulthood.
  • The onset of ICE syndrome generally occurs in early to middle adulthood.
Previous
 
 
Contributor Information and Disclosures
Author

Ingrid U Scott, MD, MPH  Professor, Department of Ophthalmology and Public Health Sciences, Pennsylvania State University College of Medicine

Ingrid U Scott, MD, MPH is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Cataract and Refractive Surgery, American Society of Retina Specialists, Association for Research in Vision and Ophthalmology, Macula Society, Phi Beta Kappa, and Retina Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Bradford Shingleton, MD  Assistant Clinical Professor of Ophthalmology, Harvard Medical School; Consulting Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary

Bradford Shingleton, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Ophthalmology

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Martin B Wax, MD  Clinical Professor, Department of Ophthalmology, University of Texas Southwestern Medical School; Vice President, Ophthalmology Research and Development, Head, Ophthalmology Discovery Research, Alcon Labs, Inc

Martin B Wax, MD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Society for Neuroscience

Disclosure: Nothing to disclose.

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Mansouri K, Sommerhalder J, Shaarawy T. Prospective comparison of ultrasound biomicroscopy and anterior segment optical coherence tomography for evaluation of anterior chamber dimensions in European eyes with primary angle closure. Eye. May 15 2009;[Medline].

  2. Kitsos G, Zikou AK, Bagli E, Kosta P, Argyropoulou MI. Conventional MRI and magnetization transfer imaging of the brain and optic pathway in primary open-angle glaucoma. Br J Radiol. May 11 2009;[Medline].

  3. Wittström E, Ponjavic V, Lövestam-Adrian M, Larsson J, Andréasson S. Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma. Acta Ophthalmol. Apr 27 2009;[Medline].

  4. Gandolfi SA, Cimino L, Sangermani C, et al. Improvement of spatial contrast sensitivity threshold after surgical reduction of intraocular pressure in unilateral high-tension glaucoma. Invest Ophthalmol Vis Sci. Jan 2005;46(1):197-201. [Medline].

  5. Jain SS, Rao P, Kothari K, et al. Posterior scleritis presenting as unilateral secondary angle-closure glaucoma. Indian J Ophthalmol. Sep 2004;52(3):241-4. [Medline].

  6. Kirsch M, Henkes H, Liebig T, et al. Endovascular management of dural carotid-cavernous sinus fistulas in 141 patients. Neuroradiology. Jul 2006;48(7):486-90. [Medline].

  7. Spiegel D, Wetzel W, Neuhann T, Stuermer J, Hoeh H, Garcia-Feijoo J, et al. Coexistent primary open-angle glaucoma and cataract: Interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery. Eur J Ophthalmol. May-Jun 2009;19(3):393-9. [Medline].

  8. Peeters A, Webers CA, Prins MH, Zeegers MP, Hendrikse F, Schouten JS. Quantifying the effect of intraocular pressure reduction on the occurrence of glaucoma. Acta Ophthalmol. Apr 27 2009;[Medline].

  9. Albert DM, Jakobiec FA, Azar DT. Glaucoma associated with increased episcleral venous pressure. In: Principles and Practice of Ophthalmology. 2nd ed. WB Saunders Co; 2000:2781-2792.

  10. Alvarado JA, Underwood JL, Green WR, et al. Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch Ophthalmol. Dec 1994;112(12):1601-9. [Medline].

  11. Cibis GW, Tripathi RC, Tripathi BJ. Glaucoma in Sturge-Weber syndrome. Ophthalmology. Sep 1984;91(9):1061-71. [Medline].

  12. Font RL, Ferry AP. The phakomatoses. Int Ophthalmol Clin. 1972;12(1):1-50. [Medline].

  13. Manor RS, Kurz O, Lewitus Z. Intraocular pressure in endocrinological patients with exophthalmos. Ophthalmologica. 1974;168(4):241-52. [Medline].

  14. Uram M, Zubillaga C. The cutaneous manifestations of Sturge-Weber syndrome. J Clin Neuroophthalmol. Dec 1982;2(4):245-8. [Medline].

  15. Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. Mar 1976;60(3):163-91. [Medline].

  16. Weiss DI. Dual origin of glaucoma in encephalotrigeminal haemangiomatosis. Trans Ophthalmol Soc U K. 1973;93(0):477-93. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.